Name: Phone: Best Time To Call: A PharmaCare representative will call to assist you and answer your questions. We will leave a brief message if you are unavailable at the time of our call.

To speak with a PharmaCare pharmacist or representative, Call 800-238-7828

Despite the availability of interferons, their treatment efficacy is moderate at best. Fortunately, the search for new treatment options is ongoing. The investigational treatments that are currently most promising include:

1. Thymosin alpha 1 - This immune system enhancer (ISE) is currently in Phase III trials. This therapy is being studied for concurrent administration with pegylated interferon therapy to improve sustained response rates.

2. Omega interferon - Phase II trials are underway to determine the effectiveness of omega interferon in patients with chronic Hepatitis C infections. Initial results have been very encouraging. The studies are also evaluating a brand new dosage delivery system that would eliminate the need for injections of interferon.

It is worth noting that the most recent breakthrough in HCV treatment is the approval of pegylated interferons. Treatment with pegylated interferon in combination with ribavirin has achieved some of the highest response rates to date

This information is provided for educational purposes only. It is not intended to be a substitute for medical advice or treatment from a health care provider or to cover all possible uses, actions, precautions, side effects or interactions. Like any printed material, it may become out-of-date over time. If you have other questions, you should discuss them with your physician or PharmaCare Pharmacist.

Back To HCV Wellness Center